Rex Fang & Innovation Equity Premium Income ETF vs NeoGenomics Inc. Common Stock — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $41.99 (market cap $744.46M), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: NeoGenomics Inc. Common Stock is far larger — about 2.9× Rex Fang & Innovation Equity Premium Income ETF's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Rex Fang & Innovation Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rex Fang & Innovation Equity Premium Income ETF for 57 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| FEPI | NEO | |
|---|---|---|
Market Cap | $744.46M | $2.14B |
Volume | 116,338 | 2,228,400 |
Sector | Income / Options Overlay | Health |
52-Week High | $49.54 | $19.91 |
52-Week Low | $37.98 | $7.19 |
Typical Hold Time | 57 Days | 0 Days |
Enterprise Value | — | $2.44B |
Signals from Pluang's Aura AI — not financial advice
FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $43.28, showing minimal daily movement with a 0.14% gain. The ETF employs a covered call strategy on AI and mega-cap tech stocks, generating substantial weekly dividends averaging $0.20-0.21 per share. Technical indicators show a bullish trend with strong moving average support, while oscillators remain neutral. Recent news highlights FEPI's 25% yield but notes underperformance compared to peers in total returns.
FEPI offers high income potential through its covered call strategy but faces capped upside and concentrated tech exposure risks. The ETF's performance depends heavily on AI sector volatility and options pricing efficiency. While attractive for income-focused investors, total return potential may lag broader market indices during strong bull markets.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →